Flagship Pioneering
Venture Capital
Biotech Venture Creation
Seed
Early Stage
Growth
Biotech
- Headquarters
- Cambridge, United States
- Founded
- 2000
- Website
- flagshippioneering.com
- AUM
- $5.3B
- Portfolio Companies
- 57
- Last Investment
- Apr 2025
- Geographic Focus
- United States
Investment Thesis
Flagship creates breakthrough bioplatform companies from inception using a principal-founder model, originating science-first ventures in life sciences and healthcare that generate multiple products from proprietary platforms.
Portfolio57
FT
Foghorn TherapeuticsC
CellarityPT
ProFound TherapeuticsMB
Metaphore BiotechnologiesM
MorphotekAP
AVEO PharmaceuticalsCK
Color KineticsSP
Syros PharmaceuticalsET
Empress Therapeutics
KB
Kaleido Biosciences
ST
Seres TherapeuticsA
AlltrnaCB
Codiak BioSciencesHH
Harbinger HealthN
NovomerMB
Mirai Bio
AB
Ampersand BiomedicinesE
EtiomeKT
KSQ TherapeuticsM
ModernaTB
Terrana Biosciences
RT
Rubius TherapeuticsA
AffinnovaAB
Apriori BioST
Sigilon TherapeuticsE
ExtuitiveIS
Invaio SciencesTT
Tarveda TherapeuticsSB
Sail BiomedicinesA
AbiologicsRT
Ring TherapeuticsIA
Indigo AgricultureMT
Montai TherapeuticsOT
Omega TherapeuticsQT
Quotient Therapeutics